D.K. Enterprises Global Limited — JV/Acquisition, 27-09-2025: Acquisition

D.K. Enterprises Global announced it will acquire 100% equity in Superior Biotec Private Limited for 1 Cr. Superior Biotec, a newly incorporated pharmaceutical entity yet to begin operations, will become a wholly-owned subsidiary. This strategic move aims to expand D.K. Enterprises' operations by establishing a new manufacturing unit, aligning with its growth strategy. The deal is expected to close by March 2026. This acquisition signals a clear intent for future growth in the pharma sector.